The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
INFL Combination
Eucalyptus Globulus, Ipecacuanha, Aconitum Napellus, Adenoviren Nosode, Influenzinum 2021-2022, Bryonia (Alba), Eupatorium Perfoliatum, Gelsemium Sempervirens, Kreosotum, Veratrum Viride · EUCALYPTUS GLOBULUS LEAF 2 [hp_C]/mL; IPECAC 3 [hp_C]/mL; ACONITUM NAPELLUS WHOLE 6 [hp_C]/mL; HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578 ANTIGEN 9 [hp_C]/mL; INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED) 10 [hp_C]/mL; INFLUENZA A VIRUS A/TASMANIA/503/2020 IVR-221 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED) 10 [hp_C]/mL; INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED) 10 [hp_C]/mL; INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED) 30 [hp_C]/mL; BRYONIA ALBA ROOT 30 [hp_C]/mL; EUPATORIUM PERFOLIATUM FLOWERING TOP 30 [hp_C]/mL; GELSEMIUM SEMPERVIRENS ROOT 30 [hp_C]/mL; WOOD CREOSOTE 30 [hp_C]/mL; VERATRUM VIRIDE ROOT 30 [hp_C]/mL · Liquid · Oral · Deseret Biologicals, Inc.
NDC 43742-2045-01 · 30 mL in 1 BOTTLE, DROPPER · UNAPPROVED HOMEOPATHIC · View full market →
Medicare Part D
Medicare Part D does not cover homeopathic products, which are not FDA-approved drugs.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- —
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- —
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Eucalyptus Globulus, Ipecacuanha, Aconitum Napellus, Adenoviren Nosode, Influenzinum 2021-2022, Bryonia (Alba), Eupatorium Perfoliatum, Gelsemium Sempervirens, Kreosotum, Veratrum Viride (Liquid)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Deseret Biologicals, Inc. | EUCALYPTUS GLOBULUS LEAF 2 [hp_C]/mL; IPECAC 3 [hp_C]/mL; ACONITUM NAPELLUS WHOLE 6 [hp_C]/mL; HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578 ANTIGEN 9 [hp_C]/mL; INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED) 10 [hp_C]/mL; INFLUENZA A VIRUS A/TASMANIA/503/2020 IVR-221 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED) 10 [hp_C]/mL; INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED) 10 [hp_C]/mL; INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED) 30 [hp_C]/mL; BRYONIA ALBA ROOT 30 [hp_C]/mL; EUPATORIUM PERFOLIATUM FLOWERING TOP 30 [hp_C]/mL; GELSEMIUM SEMPERVIRENS ROOT 30 [hp_C]/mL; WOOD CREOSOTE 30 [hp_C]/mL; VERATRUM VIRIDE ROOT 30 [hp_C]/mL | Aug 26, 2026 | Sep 2, 2026 |
| Deseret Biologicals, Inc. | EUCALYPTUS GLOBULUS LEAF 6 [hp_C]/mL; IPECAC 30 [hp_C]/mL; ACONITUM NAPELLUS WHOLE 2 [hp_C]/mL; HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578 ANTIGEN 30 [hp_C]/mL; INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED) 30 [hp_C]/mL; INFLUENZA A VIRUS A/TASMANIA/503/2020 IVR-221 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED) 9 [hp_C]/mL; INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED) 10 [hp_C]/mL; INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED) 10 [hp_C]/mL; BRYONIA ALBA ROOT 30 [hp_C]/mL; EUPATORIUM PERFOLIATUM FLOWERING TOP 10 [hp_C]/mL; GELSEMIUM SEMPERVIRENS ROOT 3 [hp_C]/mL; WOOD CREOSOTE 30 [hp_C]/mL; VERATRUM VIRIDE ROOT 30 [hp_C]/mL | Jul 22, 2026 | Aug 19, 2026 |
| Deseret Biologicals, Inc. | ACONITUM NAPELLUS WHOLE 6 [hp_C]/mL; BRYONIA ALBA ROOT 30 [hp_C]/mL; EUCALYPTUS GLOBULUS LEAF 2 [hp_C]/mL; EUPATORIUM PERFOLIATUM FLOWERING TOP 30 [hp_C]/mL; GELSEMIUM SEMPERVIRENS ROOT 30 [hp_C]/mL; HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578 ANTIGEN 9 [hp_C]/mL; INFLUENZA A VIRUS A/TASMANIA/503/2020 IVR-221 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED) 10 [hp_C]/mL; INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED) 10 [hp_C]/mL; INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED) 30 [hp_C]/mL; INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED) 10 [hp_C]/mL; IPECAC 3 [hp_C]/mL; VERATRUM VIRIDE ROOT 30 [hp_C]/mL; WOOD CREOSOTE 30 [hp_C]/mL | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "INFL Combination — NDC 43742-2045-01," retrieved September 3, 2026, https://drugdashboards.com/drug/43742204501.
Free to cite with attribution — see how the data is put together.